Subcutaneous atezolizumab for the treatment of non-small cell lung cancer.
This review article evaluates subcutaneous (SC) atezolizumab (co-formulated with rHuPH20) as an alternative to the intra...
Developmental organization of sensory and sympathetic ganglia.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:1 min read
This study investigates when and how neural crest cells (NCCs commit to specific fates, and how individual progenitors c...
Enhanced dynamic risk stratification of smoldering multiple myeloma.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:1 min read
This study develops and validates new risk models (PANGEA-SMM) to predict progression from smoldering multiple myeloma (...
Implementation of the NHS England Lung Cancer Screening Programme over 5 years.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:1 min read
This publication describes implementation outcomes from the national NHS England Targeted Lung Health Check Programme, n...
Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This publication reports the SERENA-3 presurgical window-of-opportunity trial evaluating the oral SERD camizestrant in p...
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2 breast cancer: TBCRC049 phase 2 study results.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
Phase 2, single‑arm, multicenter study of tucatinib–trastuzumab–capecitabine in HER2‑positive breast cancer with...